<DOC>
	<DOCNO>NCT00232492</DOCNO>
	<brief_summary>The purpose study determine whether equal subanesthetic dos racemic ketamine equally effective female male surgical removal third molar</brief_summary>
	<brief_title>Ketamine Acute Pain Females Males</brief_title>
	<detailed_description>Ketamine assume NMDA receptor antagonist provide analgesia acute postoperative pain ( type pain ) subanesthetic dos . Gender difference ketamine analgesia know . This placebo-controlled , randomise , parallel group study investigate analgesic dose-response effect ketamine subanesthetic dos female male patient follow surgical removal third molar . Comparisons : Placebo ketamine female male .</detailed_description>
	<mesh_term>Tooth Diseases</mesh_term>
	<mesh_term>Tooth , Impacted</mesh_term>
	<mesh_term>Stomatognathic Diseases</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Indication removal third molar Between 20 30 year age ASA Class 1 Psychiatric family ( father/mother ) anamnestic history Hypersensitivity towards NSAIDS rescue analgesic Verified suspect pregnancy Lactating female Surgery last 60 min</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Wisdom</keyword>
	<keyword>Tooth</keyword>
	<keyword>Teeth</keyword>
	<keyword>Third</keyword>
	<keyword>Molar</keyword>
</DOC>